Hermetica Superfood Encyclopedia
The Short Answer
Silibinin is the primary active flavonolignan compound found in milk thistle, representing 50-70% of the silymarin complex. It functions primarily as a hepatoprotective agent by stabilizing hepatocyte membranes and inhibiting lipid peroxidation in liver tissue.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelStrong
Primary Keywordsilibinin benefits
Synergy Pairings3
Silibinin (Flavonolignan) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Silibinin is a flavonolignan primarily derived from the seeds of the milk thistle plant (Silybum marianum), comprising the major active component of silymarin extract. It is isolated and purified through solvent extraction (typically ethanol or methanol) from the plant's fruits and seeds for pharmaceutical use in capsules or extracts.
“Silibinin, as part of silymarin from Silybum marianum, has been used in traditional European medicine for liver disorders for centuries. The milk thistle plant has documented medicinal applications for hepatoprotection dating back to traditional European herbal medicine practices.”Traditional Medicine
Scientific Research
Clinical evidence includes a 568-patient randomized controlled trial testing 210mg daily silibinin alongside TB drugs (PMC4443182), and a 30-patient double-blind RCT in rheumatoid arthritis (PMC4927723). Two meta-analyses evaluated silibinin for liver conditions: one analyzing 16 RCTs in traditional Chinese medicine combinations (PMID: 38306552) and another for alcoholic liver disease (PMC11832396).
Preparation & Dosage
Traditional preparation
Clinically studied doses include 70mg silibinin capsules taken 3 times daily (210mg total) for 8 weeks. Studies typically use standardized silymarin extracts containing 50-80% silibinin. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Silibinin (Flavonolignan) is a bioactive compound rather than a traditional nutrient, so it lacks conventional macronutrient/micronutrient profiles. It is the primary active constituent of silymarin, extracted from milk thistle (Silybum marianum) seeds, comprising approximately 50-70% of silymarin extract by weight. As a pure compound, it is typically standardized to >95% purity in pharmaceutical/research preparations. Silibinin exists as a diastereomeric mixture of silybin A and silybin B in approximately equal proportions. Molecular weight: 482.44 g/mol. It contains a flavonoid (taxifolin) linked to a phenylpropanoid (coniferyl alcohol) via an ether bond. Bioavailability is notably poor when administered orally in free form, with absolute bioavailability estimated at <1% due to low aqueous solubility and extensive first-pass metabolism; plasma half-life is approximately 6 hours. Bioavailability is significantly enhanced via phospholipid complexes (Siliphos/Silymarin-phosphatidylcholine complex), which improve absorption 4-10 fold. IV formulations (e.g., Legalon SIL) bypass bioavailability limitations entirely. It undergoes hepatic glucuronidation and sulfation, with biliary excretion being the primary elimination route (~80%). Typical therapeutic doses range from 140-800 mg/day orally; clinical trials for liver protection in TB used doses around 140-420 mg/day. No caloric or macronutrient contribution is clinically relevant at therapeutic doses.
How It Works
Mechanism of Action
Silibinin stabilizes hepatocyte cell membranes by binding to phosphatidylcholine and preventing membrane damage from free radicals. The compound inhibits 5-lipoxygenase and cyclooxygenase enzymes, reducing inflammatory prostaglandin and leukotriene production. It also modulates nuclear factor-kappa B (NF-κB) signaling pathways to decrease hepatic inflammation.
Clinical Evidence
A randomized controlled trial of 568 tuberculosis patients showed silibinin reduced AST levels at 2-4 weeks and alkaline phosphatase at 8 weeks during anti-TB treatment. The same study demonstrated improved sputum clearance with 98.30% negativity rates versus 92.98% in controls (P<0.05). However, overall hepatotoxicity rates remained similar between treatment and control groups. Current clinical evidence is limited primarily to tuberculosis-related liver protection studies.
Safety & Interactions
Silibinin is generally well-tolerated with mild gastrointestinal effects reported in some users, including nausea and diarrhea. The compound may interact with cytochrome P450 enzymes, potentially affecting metabolism of medications like warfarin and statins. Safety during pregnancy and lactation has not been established through adequate clinical trials. Individuals with hormone-sensitive conditions should use caution as silibinin may have mild estrogenic activity.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
SilybinSilybinin ASilybinin BMilk thistle flavonoidSilymarin component2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxo-4H-1-benzopyran-2-yl)-1,4-benzodioxinMariendistelikatanLady's thistle extract
Frequently Asked Questions
What is the difference between silibinin and silymarin?
Silibinin is a single flavonolignan compound that comprises 50-70% of silymarin, which is the complete standardized extract containing multiple milk thistle compounds. Silymarin includes silibinin along with silicristin, silidianin, and other related compounds.
How much silibinin should I take for liver support?
Clinical studies have used silibinin doses ranging from 140-800mg daily, typically divided into 2-3 doses with meals. The tuberculosis study showing liver protection benefits used approximately 140mg three times daily for optimal hepatic support.
Does silibinin help with fatty liver disease?
While silibinin's hepatoprotective mechanisms suggest potential benefits for fatty liver, current clinical evidence focuses primarily on tuberculosis-related liver injury. More research is needed to establish efficacy specifically for non-alcoholic fatty liver disease treatment.
Can silibinin interact with prescription medications?
Yes, silibinin may interact with medications metabolized by cytochrome P450 enzymes, including blood thinners like warfarin and cholesterol medications. It can potentially alter drug metabolism rates and should be discussed with healthcare providers before combining with prescriptions.
How long does it take for silibinin to show liver benefits?
Clinical evidence suggests silibinin may reduce liver enzyme levels (AST) within 2-4 weeks of consistent use, with alkaline phosphatase improvements observed at 8 weeks. Individual response times may vary based on baseline liver function and underlying conditions.
What is the most bioavailable form of silibinin?
Silibinin phytosome (also called silipide) is the most bioavailable form, as it binds silibinin to phospholipids to enhance absorption compared to standard silymarin extracts. Studies show phytosome formulations achieve 2-3 times higher blood levels of silibinin than conventional extracts. Look for products specifically labeled as silibinin phytosome or phytocomplex for optimized bioavailability.
Can silibinin help with tuberculosis treatment side effects?
Research suggests silibinin may help protect liver function during TB drug therapy—a 568-patient trial showed it reduced AST liver enzyme levels at 2-4 weeks and AKP at 8 weeks. Additionally, silibinin demonstrated potential benefits for sputum clearance in TB patients, with 98.30% negativity in the silibinin group versus 92.98% in controls. However, consult your healthcare provider before combining silibinin with TB medications due to potential interactions.
Is silibinin beneficial for rheumatoid arthritis?
Early research indicates silibinin may support rheumatoid arthritis symptom management through improvements in DAS28 inflammatory scores, though studies are still limited in scope. The anti-inflammatory and antioxidant properties of silibinin make it a candidate for joint health support, but more robust clinical trials are needed to establish efficacy. If considering silibinin for RA, work with a rheumatologist since it may interact with immunosuppressive medications commonly used in RA treatment.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w silibinin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
